Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | EVP-COO | December 17, 2018 | December 19, 2018 |
| INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234 | Director | May 01, 2026 | May 05, 2026 |
| J M SMUCKER CoSJM · Entity 627 | Director | October 01, 2026 | October 02, 2026 |
| TE Connectivity plcTEL · Entity 3004 | Director | November 13, 2025 | November 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date December 17, 2018 · Filed December 19, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,586 |
Ending reported balance
After 2018-12-17 transaction · row 10
10 source rows · reconciled sequenceRow 1 · 2018-12-17 · Exercise / conversion · Acquired 11,550 · Balance 28,244 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Row 2 · 2018-12-17 · Exercise / conversion · Acquired 8,829 · Balance 37,073 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Row 3 · 2018-12-17 · Exercise / conversion · Acquired 6,830 · Balance 43,903 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Row 4 · 2018-12-17 · Sale · Disposed 600 · Balance 43,303 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2: This transaction was executed in multiple trades at prices ranging from $163.93 to $164.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 5 · 2018-12-17 · Sale · Disposed 800 · Balance 42,503 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3: This transaction was executed in multiple trades at prices ranging from $162.89 to $163.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 6 · 2018-12-17 · Sale · Disposed 1,300 · Balance 41,203 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4: This transaction was executed in multiple trades at prices ranging from $161.88 to $162.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 7 · 2018-12-17 · Sale · Disposed 2,100 · Balance 39,103 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F5: This transaction was executed in multiple trades at prices ranging from $158.76 to $159.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 8 · 2018-12-17 · Sale · Disposed 2,406 · Balance 36,697 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F6: This transaction was executed in multiple trades at prices ranging from $157.56 to $158.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 9 · 2018-12-17 · Sale · Disposed 9,011 · Balance 27,686 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F7: This transaction was executed in multiple trades at prices ranging from $160.85 to $161.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 10 · 2018-12-17 · Sale · Disposed 9,100 · Balance 18,586 F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F8: This transaction was executed in multiple trades at prices ranging from $159.84 to $160.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.09 · Expires 2023-01-02 | Direct | 0 |
Reported balance
After 2018-12-17 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-12-17 · Exercise / conversion · Disposed 6,830 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.11 · Expires 2022-09-11 | Direct | 0 |
Reported balance
After 2018-12-17 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2018-12-17 · Exercise / conversion · Disposed 11,550 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.45 · Expires 2023-09-17 | Direct | 11,661 |
Reported balance
After 2018-12-17 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2018-12-17 · Exercise / conversion · Disposed 8,829 · Balance 11,661 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 930 |
Reported balance
Holding disclosure · report date 2018-12-17 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 930 |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: This transaction was executed in multiple trades at prices ranging from $163.93 to $164.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $162.89 to $163.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $161.88 to $162.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $158.76 to $159.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: This transaction was executed in multiple trades at prices ranging from $157.56 to $158.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7: This transaction was executed in multiple trades at prices ranging from $160.85 to $161.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8: This transaction was executed in multiple trades at prices ranging from $159.84 to $160.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
INTERNATIONAL FLAVORS & FRAGRANCES INC
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-05-01 | Direct | 0 |
Reported balance
After 2026-05-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-01 · Disposition to issuer · Disposed 2,569 · Balance 0 F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2: Represent RSUs granted under the Non-Employee Director Compensation Program. F4: Upon the vesting of RSUs on May 1, 2026, the reporting person deferred the receipt of 2,569 shares of Common Stock and received instead 2,569 Stock Equivalent Units ("Units") pursuant to the Company's deferredcompensation plan. F3: On May 1, 2025, the reporting person was granted 2,569 RSUs, all of which vested on May 1, 2026. |
| Stock Equivalent UnitSEC Table II · derivative / convertible security | Direct | 2,569 |
Reported balance
After 2026-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-01 · Grant · Acquired 2,569 · Balance 2,569 F5: The Units convert to Common Stock on a one-for-one basis. F4: Upon the vesting of RSUs on May 1, 2026, the reporting person deferred the receipt of 2,569 shares of Common Stock and received instead 2,569 Stock Equivalent Units ("Units") pursuant to the Company's deferredcompensation plan. F6: The Units are payable in Common Stock upon the earlier of the reporting person ceasing to serve as a member of the Company's Board of Directors or January 1 following retirement. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.
F2: Represent RSUs granted under the Non-Employee Director Compensation Program.
F3: On May 1, 2025, the reporting person was granted 2,569 RSUs, all of which vested on May 1, 2026.
F4: Upon the vesting of RSUs on May 1, 2026, the reporting person deferred the receipt of 2,569 shares of Common Stock and received instead 2,569 Stock Equivalent Units ("Units") pursuant to the Company's deferredcompensation plan.
F5: The Units convert to Common Stock on a one-for-one basis.
F6: The Units are payable in Common Stock upon the earlier of the reporting person ceasing to serve as a member of the Company's Board of Directors or January 1 following retirement.
J M SMUCKER Co
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 18,581.042 |
Reported balance
After 2026-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 1,466 · Balance 18,581.042 F1: Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director. F2: This amount includes shares acquired under the Company's dividend reinvestment plan, as administered by its transfer agent. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director.
F2: This amount includes shares acquired under the Company's dividend reinvestment plan, as administered by its transfer agent.
TE Connectivity plc
Report date November 13, 2025 · Filed November 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 6,845 |
Ending reported balance
After 2025-11-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-11-13 · Grant · Acquired 838 · Balance 7,248 F1: Grant of shares by the Issuer under directors' compensation program and Issuer's stock and incentive plan. Row 2 · 2025-11-13 · Tax withholding · Disposed 403 · Balance 6,845 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of shares by the Issuer under directors' compensation program and Issuer's stock and incentive plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 17, 2018 Filed Dec 19, 2018 23:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 800 | $163.47 | $130,778.00 |
DisclosureSEC source: 0001225208-18-016933 · doc4.xml · nonDerivative · entry 5 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,503 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: This transaction was executed in multiple trades at prices ranging from $162.89 to $163.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 600 | $164.12 | $98,474.52 |
DisclosureSEC source: 0001225208-18-016933 · doc4.xml · nonDerivative · entry 4 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,303 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: This transaction was executed in multiple trades at prices ranging from $163.93 to $164.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 6,830 | $74.09 | $506,034.70 |
DisclosureSEC source: 0001225208-18-016933 · doc4.xml · nonDerivative · entry 3 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 8,829 | $84.45 | $745,609.05 |
DisclosureSEC source: 0001225208-18-016933 · doc4.xml · nonDerivative · entry 2 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 11,550 | $72.11 | $832,870.50 |
DisclosureSEC source: 0001225208-18-016933 · doc4.xml · nonDerivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on September 5, 2018, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| December 04, 2018 Filed Dec 8, 2018 01:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,375 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-18-016342 · doc4.xml · derivative · entry 7 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,375 Underlying: Common Stock · 16,375 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2018 Filed Dec 8, 2018 01:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,235 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-18-016342 · doc4.xml · derivative · entry 6 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,705 Underlying: Common Stock · 10,235 shares Expires 2027-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2018 Filed Dec 8, 2018 01:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 23,342 | $164.53 | $3,840,519.95 |
DisclosureSEC source: 0001225208-18-016342 · doc4.xml · nonDerivative · entry 4 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,694 F2 · price: This transaction was executed in multiple trades at prices ranging from $164.00 to $165.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 04, 2018 Filed Dec 8, 2018 01:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 2,608 | $165.14 | $430,680.69 |
DisclosureSEC source: 0001225208-18-016342 · doc4.xml · nonDerivative · entry 3 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,036 F1 · price: This transaction was executed in multiple trades at prices ranging from $165.0050 to $165.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 04, 2018 Filed Dec 8, 2018 01:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 10,235 | $135.57 | $1,387,558.95 |
DisclosureSEC source: 0001225208-18-016342 · doc4.xml · nonDerivative · entry 2 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2018 Filed Dec 8, 2018 01:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 16,375 | $123.09 | $2,015,598.75 |
DisclosureSEC source: 0001225208-18-016342 · doc4.xml · nonDerivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2018 Filed Dec 8, 2018 01:23 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GiftCommon Stock | 2,481.9229 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-016342 · doc4.xml · nonDerivative · entry 5 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 930 F3 · kind: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 21:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,380 | $0.00 Strike: $97.23 | $0.00 |
DisclosureSEC source: 0001225208-18-015317 · doc4.xml · derivative · entry 8 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,380 shares Expires 2024-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 21:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 23,440 | $0.00 Strike: $89.82 | $0.00 |
DisclosureSEC source: 0001225208-18-015317 · doc4.xml · derivative · entry 7 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,440 shares Expires 2024-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 21:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,815 | $0.00 Strike: $111.60 | $0.00 |
DisclosureSEC source: 0001225208-18-015317 · doc4.xml · derivative · entry 6 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,605 Underlying: Common Stock · 22,815 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 21:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 54,205 | $157.39 | $8,531,091.87 |
DisclosureSEC source: 0001225208-18-015317 · doc4.xml · nonDerivative · entry 4 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,034 F1 · price: This transaction was executed in multiple trades at prices ranging from $157.06 to $157.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 21:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 10,380 | $97.23 | $1,009,247.40 |
DisclosureSEC source: 0001225208-18-015317 · doc4.xml · nonDerivative · entry 3 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 21:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 22,815 | $111.60 | $2,546,154.00 |
DisclosureSEC source: 0001225208-18-015317 · doc4.xml · nonDerivative · entry 2 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 21:26 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 23,440 | $89.82 | $2,105,380.80 |
DisclosureSEC source: 0001225208-18-015317 · doc4.xml · nonDerivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:45 UTC | J M SMUCKER Co SJM · Entity 627 | GrantDeferred Stock Units · Derivative | 1,317 | $102.51 Strike: $0.00 | $135,005.67 |
DisclosureSEC source: 0001127602-18-029452 · form4.xml · derivative · entry 1 Willoughby Dawn C · CIK 0001565196 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,644.073 Underlying: Common Shares · 1,317 shares Expires not disclosed F1 · derivative.exercise_date: Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director. F1 · derivative.expiration_date: Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director. F2 · balance_after: This amount includes shares acquired under the Company's dividend reinvestment plan, as administered by its transfer agent. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 22:05 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 30,240 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-18-013651 · doc4.xml · derivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,240 Underlying: Common Stock · 30,240 shares Expires 2028-09-18 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 20:21 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 3,387 | $148.01 | $501,308.52 |
DisclosureSEC source: 0001225208-18-013249 · doc4.xml · nonDerivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,604 F1 · price: This transaction was executed in multiple trades at prices ranging from $148.00 to $148.011. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 183 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 2,166 | $146.77 | $317,903.82 |
DisclosureSEC source: 0001225208-18-012765 · doc4.xml · nonDerivative · entry 2 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,808 F2 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 5,370 | $146.77 | $788,154.90 |
DisclosureSEC source: 0001225208-18-012765 · doc4.xml · nonDerivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,974 F1 · kind: Settlement of 2015 Performance Unit Grant that vested 8/16/2018. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 23:12 UTC Amendment | J M SMUCKER Co SJM · Entity 627 | GrantDeferred Stock Units · Derivative | 1,290 | $104.72 Strike: $0.00 | $135,088.80 |
DisclosureSEC source: 0001127602-17-029279 · form4a.xml · derivative · entry 1 Willoughby Dawn C · CIK 0001565196 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290 Underlying: Common Shares · 1,290 shares Expires not disclosed F1 · derivative.exercise_date: Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director. F1 · derivative.expiration_date: Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:09 UTC | J M SMUCKER Co SJM · Entity 627 | GrantDeferred Stock Units · Derivative | 1,290 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-029248 · form4.xml · derivative · entry 1 Willoughby Dawn C · CIK 0001565196 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290 Underlying: Common Shares · 1,290 shares Expires not disclosed F1 · derivative.exercise_date: Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director. F1 · derivative.expiration_date: Deferred Stock Units are payable in Common Shares at a rate of 1-for-1 following termination of services as a director. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:28 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 40,940 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-17-015019 · doc4.xml · derivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,940 Underlying: Common Stock · 40,940 shares Expires 2027-09-12 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| August 29, 2017 Filed Aug 31, 2017 20:36 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 2,158 | $138.00 | $297,804.00 |
DisclosureSEC source: 0001225208-17-014438 · doc4.xml · nonDerivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,604 F1 · balance_after: Includes 240 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 22:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 1,416 | $137.17 | $194,232.72 |
DisclosureSEC source: 0001225208-17-014209 · doc4.xml · nonDerivative · entry 4 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,522 F2 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 22:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 728 | $137.17 | $99,859.76 |
DisclosureSEC source: 0001225208-17-014209 · doc4.xml · nonDerivative · entry 3 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,938 F2 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 22:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 1,935 | $137.17 | $265,423.95 |
DisclosureSEC source: 0001225208-17-014209 · doc4.xml · nonDerivative · entry 2 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,666 F1 · kind: Settlement of 2014 Performance Unit Grant that vested 8/17/2017. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 22:06 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 3,765 | $137.17 | $516,445.05 |
DisclosureSEC source: 0001225208-17-014209 · doc4.xml · nonDerivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,731 F1 · kind: Settlement of 2014 Performance Unit Grant that vested 8/17/2017. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 23:12 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,230 | $134.54 | $300,024.20 |
DisclosureSEC source: 0001225208-17-007693 · doc4.xml · nonDerivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,966 F1 · kind: The Restricted Stock Units will vest on the third anniversary of the grant date. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 20:54 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 32,750 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-16-039397 · doc4.xml · derivative · entry 1 Willoughby Dawn C · CIK 0001565196 · EVP-COO - Cleaning, Int'nl 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,750 Underlying: Common Stock · 32,750 shares Expires 2026-09-13 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.